Search results for "Antihypertensive Agents"

showing 10 items of 184 documents

Prevalence of Uncontrolled Hypertension in Patients With Fabry Disease

2017

Background Fabry disease is a rare X-linked disease arising from deficiency of α-galactosidase A. It results in early death related to renal, cardiac, and cerebrovascular disease, which are also important outcomes in patients with elevated blood pressure (BP). The prevalence of uncontrolled hypertension, as well as the effect of enzyme replacement therapy on BP, in patients with Fabry disease is unknown. Methods We examined uncontrolled hypertension (systolic BP [SBP] ≥130 mm Hg or diastolic BP [DBP] ≥80 mm Hg) among 391 patients with Fabry disease who were participating in the Fabry Outcome Survey (FOS). Results Uncontrolled hypertension was present in 57% of men and 47% of women. In patie…

Malemedicine.medical_specialtymedicine.medical_treatmentDiastoleRenal functionBlood PressureKidneyInternal medicinePrevalenceInternal MedicinemedicineHumansSex Ratiocardiovascular diseasesAntihypertensive AgentsKidney transplantationDialysisbusiness.industryEnzyme replacement therapymedicine.diseaseKidney TransplantationFabry diseaseSurgeryBlood pressureHypertensionCardiologyFabry DiseaseFemalebusinessDialysiscirculatory and respiratory physiologyKidney diseaseAmerican Journal of Hypertension
researchProduct

Antihypertensive effects of lactoferrin hydrolyzates: Inhibition of angiotensin- and endothelin-converting enzymes

2013

The potential of bovine lactoferrin (LF) as a source of antihypertensive peptides acting on the renin-angiotensin system (RAS) and the endothelin (ET) system as dual vasopeptidase inhibitors has been examined. For this purpose enzymatic LF hydrolyzates (LFHs) were generated by trypsin and proteinase K digestions. Permeate fractions with molecular masses lower than 3 kDa (LFH <3 kDa) were orally administered to spontaneously hypertensive rats (SHRs). Although both LFHs <3 kDa showed in vitro angiotensin I-converting enzyme (ACE)-inhibitory activity, only proteinase K LFH <3 kDa exerted an in vivo antihypertensive effect. The proteinase K LFH <3 kDa and a previously characterized pepsin LFH <…

Malemedicine.medical_treatmentLactoferrin hydrolyzatesMolecular Sequence DataPeptideAngiotensin-Converting Enzyme InhibitorsBlood PressureIn Vitro TechniquesPeptidyl-Dipeptidase AECE-dependent vasoconstrictionAnalytical ChemistryIn vivoRats Inbred SHRmedicineVasopeptidase InhibitorsAnimalsAmino Acid SequenceAntihypertensive Agentschemistry.chemical_classificationProteasebiologyLactoferrinEndothelinsHydrolysisGeneral MedicineVasopeptidase inhibitorsRenin–angiotensin systemProteinase KTrypsinEndothelin systemRatsLactoferrinEnzymeCarotid ArteriesBiochemistrychemistryVasoconstrictionHypertensionbiology.proteinCattleRabbitsFood Sciencemedicine.drugACE-dependent vasoconstriction
researchProduct

Blood pressure values and depression in hypertensive individuals at high cardiovascular risk

2014

Background: Hypertension and depression are both important risk factors for cardiovascular diseases. Nevertheless, the association of blood pressure on and depression has not been completely established. This study aims to analyze whether depression may influence the control of blood pressure in hypertensive individuals at high cardiovascular risk. Methods: Cross-sectional study, embedded within the PREDIMED clinical trial, of 5954 hypertensive patients with high cardiovascular risk factor profiles. The relationship between blood pressure control and depression was analyzed. A multivariate analysis (logistic and log-linear regression), adjusting for potential confounders (socio-demographic …

Malemodelos logísticoshumanosdepresiónBlood PressureClinical trialsRisk FactorsOdds RatioMedicineDepressió psíquicamediana edadDepression (differential diagnoses)Aged 80 and overancianoantidepresivosDepressionresultado del tratamientomodelos linealesdistribución de la ji al cuadradoMiddle Agedcociente de probabilidades relativasAntidepressive AgentsTreatment OutcomeMental depressionCardiovascular diseasesHypertensionBlood pressureCardiologyHipertensióCardiology and Cardiovascular MedicineResearch Articlepresión sanguíneamedicine.medical_specialtyPressió sanguíniaInternal medicineDiabetes mellitusHumansfactores de riesgoanálisis multifactorialRisk factorAntihypertensive AgentsAgedAngiologyChi-Square DistributionMalalties cardiovascularsbusiness.industryOdds ratiomedicine.diseaseSurgeryCross-Sectional StudiesLogistic ModelsBlood pressureMultivariate AnalysisLinear ModelsantihipertensivoshipertensiónbusinessBody mass indexDyslipidemiaestudios transversalesAssaigs clínicsBMC Cardiovascular Disorders
researchProduct

Central retinal artery occlusion-A new, provisional treatment approach.

2019

The retinal ganglion cells infarcted in central retinal artery occlusion (CRAO) are the somata of the optic nerve axons, part of the central nervous system. Consequently, CRAO with inner retinal infarction is a small vessel stroke, usually with the devastating consequence of severe visual loss in the affected eye. At present, there is no generally accepted, evidence-based therapy of nonarteritic CRAO in contrast to ischemic cerebral stroke that has well-accepted treatment protocols. Widely divergent and controversial therapeutic options for CRAO reflect the desperation of treating physicians and disparate conflicting studies. We examine reasons why treatment of nonarteritic CRAO remains pro…

MassageRetinal Ganglion Cellsmedicine.medical_specialtybusiness.industryRetinal Artery OcclusionAnticoagulantsCherry-red spotCerebral strokemedicine.diseaseRetinal ganglionOphthalmologyFibrinolytic AgentsOphthalmologyOptic nerveMedicineCentral retinal artery occlusionHumansSmall vesselmedicine.symptombusinessStrokeAntihypertensive AgentsIntraocular PressureRetinal infarctionSurvey of ophthalmology
researchProduct

Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate

2010

The aim of the present study was to develop a sumatriptan succinate transdermal system for applying migraine treatments efficiently and easily. For this system polyvinyl alcohol was employed as a matrix and Azone((R)) was added as a permeability enhancer. The physical characteristics, mechanical properties, and in vivo bioadhesion of the systems were evaluated, as was in vitro permeation across porcine skin. A uniform distribution of the drug in the matrix was observed, and moisture uptake values were constant. With regard to mechanical parameters, occlusive layer inclusion made the system more resistant, and no significant differences were detected with respect to other systems. Although A…

Materials scienceChemistry PharmaceuticalDrug CompoundingMigraine DisordersSkin AbsorptionPharmaceutical SciencePharmacologyAdministration CutaneousPolyvinyl alcoholPermeabilitychemistry.chemical_compoundDrug Delivery SystemsDrug StabilityIn vivoSumatriptan SuccinatemedicineTechnology PharmaceuticalVasoconstrictor AgentsDrug InteractionsAntihypertensive AgentsTransdermalDrug CarriersSumatriptanAzepinesGeneral MedicineHydrogen-Ion ConcentrationPermeationSerotonin Receptor AgonistsSumatriptanSolubilitychemistryPermeability (electromagnetism)Polyvinyl AlcoholPolyvinylsAzoneBiomedical engineeringmedicine.drugDrug Delivery
researchProduct

The metabolic syndrome: Definition, diagnosis and management

2008

The metabolic syndrome (MetS) constitutes a major public health problem in the developed countries.(1) It is cited with different names, such as syndrome X, insulin resistance syndrome, Reaven's syndrome or CHAOS (Australia). MetS increases the cardiovascular risk, but with specific lifestyle changes and individualized drug treatment the development of serious vascular complications can be avoided. In the last years, MetS has become a prevalent clinical condition. Therefore, it is necessary to create a complete document on the diagnosis and clinical management of MetS to avoid the confusion that derives from the vast amount of scientific papers, different revisions and definitions of the sy…

Metabolic SyndromeSettore MED/09 - Medicina InternaTHE METABOLIC SYNDROME: DEFINITION DIAGNOSIS AND MANAGEMENTRisk AssessmentEatingTreatment OutcomeCardiovascular DiseasesRisk FactorsTerminology as TopicHumansHypoglycemic AgentsAnti-Obesity AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsExerciseLife StyleAntihypertensive Agents
researchProduct

Characterization of diorganotin(IV) complexes with captopril. The first crystallographically authenticated metal complex of this anti-hypertensive ag…

2003

Abstract Diorganotin(IV) complexes R 2 Sn(cap) (capH 2 = N -[( S )-3-mercapto-2-methylpropionyl]- l -proline; R=Me, Et, n -Bu and t -Bu) were prepared and characterised. The FTIR and Raman spectra demonstrated that the organotin(IV) moieties interact with the {S} atom of the ligand, while the other coordination sites are the carboxylate and the amide –CO groups. Mossbauer Δ data showed that the diorganotin(IV) compounds adopt slightly distorted trigonal-bipyramidal (tbp) geometry. A single-crystal X-ray study was performed on the compound Me 2 Sn(cap): the Sn atom is five-coordinated in a distorted tbp environment, with two {O} atoms in the axial positions and the {S} and two {C} atoms in t…

Models MolecularCaptoprilMagnetic Resonance SpectroscopyCrystallography X-RaySpectrum Analysis RamanBiochemistryInorganic ChemistryMetalSpectroscopy Mossbauerchemistry.chemical_compoundsymbols.namesakeAmideSpectroscopy Fourier Transform InfraredMössbauer spectroscopyAtomOrganotin CompoundsCarboxylateFourier transform infrared spectroscopyAntihypertensive AgentsLigandCrystallographychemistryvisual_artsymbolsvisual_art.visual_art_mediumRaman spectroscopyJournal of Inorganic Biochemistry
researchProduct

Assessment of blood pressure early morning rise

2002

Myocardial InfarctionAssessment and DiagnosisDrug Administration ScheduleMedical RecordsInternal MedicineHumansMedicineWakefulnessLife StyleAntihypertensive AgentsMorningAdvanced and Specialized Nursingbusiness.industryIncidenceBlood Pressure DeterminationGeneral MedicineBlood Pressure Monitoring AmbulatoryCircadian RhythmSelf CareStrokeDeath Sudden CardiacBlood pressureAnesthesiaHypertensionDisease SusceptibilitySleepCardiology and Cardiovascular MedicinebusinessBlood Pressure Monitoring
researchProduct

Topical glaucoma medications – Clinical implications for the ocular surface

2022

Glaucoma is a leading cause of irreversible blindness. The use of topical eye drops to reduce intraocular pressure remains the mainstay treatment. These eye drops frequently contain preservatives designed to ensure sterility of the compound. A growing number of clinical and experimental studies report the detrimental effects of not only these preservatives but also the active pharmaceutical compounds on the ocular surface, with resultant tear film instability and dry eye disease. Herein, we critically appraise the published literature exploring the effects of preservatives and pharmaceutical compounds on the ocular surface. publishedVersion

Oorganisk kemiPreservatives PharmaceuticalGlaucomaMeibomian gland dysfunctionInorganic ChemistryOphthalmologyVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Oftalmologi: 754:Medisinske Fag: 700 [VDP]TearsTopical medicationsHumansEyedropsDry Eye SyndromesDry eye diseaseOphthalmic SolutionsDry eye disease; Eyedrops; Glaucoma; Meibomian gland dysfunction; Topical medicationsAntihypertensive AgentsIntraocular Pressure
researchProduct

Hypertension in the metabolic syndrome: Summary of the new position statement of the European Society of Hypertension

2009

Arterial hypertension is often part of a larger constellation of anthropometric and metabolic abnormalities that includes abdominal (or visceral) obesity, characteristic dyslipidemia (low high-density lipoprotein cholesterol and high triglycerides), glucose intolerance, insulin resistance and hyperuricemia. Using Adult Treatment Panel III criteria, prevalence is higher than in the general population and the metabolic syndrome (MS) can be found in as many as one third of patients. In hypertensives with MS, a high prevalence of hypertension-induced target organ damage and a negative prognostic value have been described. Dietary advice and life style changes should be strongly recommended and …

Pediatricsmedicine.medical_specialtyPopulationComorbidityInsulin resistanceInternal MedicinePrevalenceMedicineHumansHyperuricemiaeducationAntihypertensive AgentsSocieties MedicalMetabolic Syndromeeducation.field_of_studybusiness.industrymedicine.diseaseComorbidityObesityEuropeBlood pressureHypertensionPractice Guidelines as TopicMetabolic syndromebusinessRisk Reduction BehaviorDyslipidemia
researchProduct